ACTC has been into the 5 and 6 cent range several times over the past years. Since that time, Phase I results indicate good success and the overall science for regenerative medicine is stronger and more promising than ever in all fields. I am betting to be a part of it with ACTC and at least one other high risk player. No risk, no gain. If you want dividends invest elsewhere.
Thanks for sharing. Wish I had a hottie to recommend, but still surfing for info. I am watching BHRT for some solid indications, but a very long shot. In other bio, I like ADHXF with good institutional ownership, but waiting for recent run up to settle down to a buy price.